Related Experiment Video
Updated: Aug 29, 2026

Through the Looking Glass: Time-lapse Microscopy and Longitudinal Tracking of Single Cells to Study Anti-cancer Therapeutics
Published on: May 14, 2016
Regulation of cell growth by selective COX-2 inhibitors in oral carcinoma cell lines
1Department of Dentistry, Tri-Service General Hospital, National Defense Medical Center, Taipei, Taiwan, ROC.
Abstract:
Evidence indicates that NSAIDs that inhibit prostaglandin (PG) synthesis can reduce the incidence of colorectal cancers and that inhibition of cyclooxygenase-2 (COX-2) may be the underlying mechanism. The objective of this study was to investigate this putative mechanism by examining the effect of selective COX-2 inhibitors (Celebrex, DFU, NS-398) and COX-1 inhibitors (Aspirin) on the growth of two human oral carcinoma cell lines (OEC-M1 and KB) and one normal fibroblast cell line (NF). We found that the growth of OEC-M1 cells could be significantly inhibited by DFU concentrations above 30 microM (31%) after 4 days, and above 50 microM (35%) after 2 days in culture; by Celebrex at concentrations above 20 microM (52%) after 6 days, above 30 microM (36%) after 5 days, and above 40 microM (33%) after 4 days in culture; and by NS-398 above 1 microM (30%) after 6 days, and above 10 microM (35%) after 5 days in culture. The growth of KB cells could be significantly inhibited by DFU concentrations above 10 microM (33%) after 6 days, above 20 microM (35%) after 4 days in culture; and by Celebrex at concentrations above 10 microM (33%) after 5 days, and above 50 microM (30%) after 4 days in culture; and by NS-398 above 1 microM (45%) after 5 days, above 20 microM (36%) after 4 days in culture. The growth of NF cells could be significantly inhibited by DFU above 30 microM (45%) after 6 days, and above 40 microM (32%) after 3 days in culture, and by Celebrex at concentrations above 10 microM (42%) after 6 days, above 30 microM (31%) after 4 days, above 50 microM (32%) after 3 days in culture, and by NS-398 above 0.1 microM (35%) after 4 days, and above 1 microM (32%) after 3 days in culture. The growth-inhibitory concentration (IC50) values for DFU on OEC-M1, KB, and NF cells were about 39.1, 14.8, and 42.9 microM at 144 h, respectively, and on KB was about 45.2 microM at 120 h. The IC50 values for Celebrex on OEC-M1, KB, and NF cells were about 19.1, 8.6, and 15.8 microM at 144 h, respectively, and on KB and NF were about 27.7 and 35.3 microM, respectively, at 120 h. The IC50 values for NS-398 on OEC-M1, KB, and NF were about 18.9, 0.7 and 1 microM, respectively, at 144 h; on KB and NF values were about 10.8 and 1.4 microM, respectively, at 120 h and on KB and NF were about 26.6 and 4.1 microM, respectively, at 96 h. The results show that the growth of these cell lines is inhibited by three COX-2 selective inhibitors but not by any COX-1 selective inhibitors. These findings suggest that COX-2 may play an important role in the generation of biochemical mediators that stimulate the growth of human oral cancer and normal fibroblast cell lines.
Insights
Selective cyclooxygenase-2 (COX-2) inhibitors significantly inhibited oral cancer cell growth, suggesting COX-2 plays a role in oral cancer progression. Non-steroidal anti-inflammatory drugs targeting COX-2 show potential for oral cancer treatment.
Area of Science:
- Oncology
- Pharmacology
- Biochemistry
Background:
- Non-steroidal anti-inflammatory drugs (NSAIDs) inhibiting prostaglandin synthesis are linked to reduced colorectal cancer incidence.
- Cyclooxygenase-2 (COX-2) inhibition is a proposed mechanism for NSAID-mediated cancer chemoprevention.
Purpose of the Study:
- To investigate the role of COX-2 in oral cancer by examining the effects of selective COX-2 inhibitors on oral carcinoma cell lines.
- To compare the efficacy of selective COX-2 inhibitors (Celebrex, DFU, NS-398) versus a COX-1 inhibitor (Aspirin) on oral cancer cell growth.
Main Methods:
- Treatment of human oral carcinoma cell lines (OEC-M1, KB) and a normal fibroblast cell line (NF) with varying concentrations of selective COX-2 inhibitors and COX-1 inhibitors.
- Assessment of cell growth inhibition over different time periods (2-6 days).
- Determination of half-maximal inhibitory concentration (IC50) values for the inhibitors on the cell lines.
Main Results:
- Selective COX-2 inhibitors (DFU, Celebrex, NS-398) significantly inhibited the growth of both OEC-M1 and KB oral cancer cell lines.
- The COX-1 inhibitor Aspirin did not show significant growth inhibition.
- NS-398 demonstrated the lowest IC50 values, indicating potent inhibition of oral cancer cell growth.
Conclusions:
- COX-2 selective inhibitors effectively suppress the growth of human oral carcinoma cell lines.
- These findings support the hypothesis that COX-2 is involved in the proliferation of oral cancer cells.
- Targeting COX-2 may represent a viable therapeutic strategy for human oral cancer.
More Related Videos
Related Concept Videos
Inhibition of Cdk Activity
Inhibition of CDK Activity
Molecular Factors Affecting Cell Division
Several proteins function as internal regulators to ensure each cell cycle stage is completed faithfully before proceeding to the next. Regulator molecules may act directly or influence the activity or production of other...
Positive Regulator Molecules
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
The Cell Cycle Control System

